Published in Hepatitis Weekly, August 14th, 2000
The study, published in Cancer Letters (2000;155:121-127), was conducted at the NIH's National Cancer Institute (NCI) by Terry W. Moody, PhD and his colleagues. The effects of Zadaxin were investigated using a mouse model of urethane-induced tumor carcinogenesis.
Daily administration of Zadaxin, after injection of urethane, significantly increased white blood cell counts and reduced the number of lung tumors. After 2.5 months of...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.